MEP11908A - (1-phenacy-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same - Google Patents
(1-phenacy-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the sameInfo
- Publication number
- MEP11908A MEP11908A MEP-119/08A MEP11908A MEP11908A ME P11908 A MEP11908 A ME P11908A ME P11908 A MEP11908 A ME P11908A ME P11908 A MEP11908 A ME P11908A
- Authority
- ME
- Montenegro
- Prior art keywords
- production
- pharmaceutical compositions
- compositions containing
- phenacy
- piperidylethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9901593A FR2789389B3 (fr) | 1999-02-10 | 1999-02-10 | Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant |
FR9904429A FR2789390B3 (fr) | 1999-02-10 | 1999-04-07 | Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant |
PCT/FR2000/000284 WO2000047572A1 (fr) | 1999-02-10 | 2000-02-08 | Derives de (1-phenacy-3-phenyl-3-piperidylethyl)piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
MEP11908A true MEP11908A (en) | 2010-06-10 |
Family
ID=26234812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-119/08A MEP11908A (en) | 1999-02-10 | 2000-02-08 | (1-phenacy-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
Country Status (37)
Country | Link |
---|---|
US (2) | US6642233B1 (cs) |
EP (1) | EP1150970B1 (cs) |
JP (1) | JP4648544B2 (cs) |
KR (1) | KR100611261B1 (cs) |
CN (1) | CN1273463C (cs) |
AR (1) | AR028813A1 (cs) |
AT (1) | ATE370942T1 (cs) |
AU (1) | AU763716B2 (cs) |
BG (1) | BG65031B1 (cs) |
BR (1) | BR0008067A (cs) |
CA (1) | CA2360894C (cs) |
CO (1) | CO4980896A1 (cs) |
CZ (1) | CZ300765B6 (cs) |
DE (1) | DE60036081T2 (cs) |
DK (1) | DK1150970T3 (cs) |
EE (1) | EE04437B1 (cs) |
ES (1) | ES2291187T3 (cs) |
FR (1) | FR2789390B3 (cs) |
HK (1) | HK1038927A1 (cs) |
HR (1) | HRP20010566A2 (cs) |
HU (1) | HUP0201281A3 (cs) |
ID (1) | ID29219A (cs) |
IL (2) | IL144363A0 (cs) |
ME (1) | MEP11908A (cs) |
NO (2) | NO321149B1 (cs) |
NZ (1) | NZ513053A (cs) |
PE (1) | PE20001463A1 (cs) |
PL (1) | PL198561B1 (cs) |
PT (1) | PT1150970E (cs) |
RS (1) | RS50210B (cs) |
RU (1) | RU2220956C2 (cs) |
SI (1) | SI1150970T1 (cs) |
SK (1) | SK286401B6 (cs) |
TR (1) | TR200102331T2 (cs) |
TW (1) | TWI254712B (cs) |
UA (1) | UA70986C2 (cs) |
WO (1) | WO2000047572A1 (cs) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050009798A1 (en) | 2002-02-20 | 2005-01-13 | Sepracor Inc. | Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists |
AU2003217535A1 (en) * | 2002-02-20 | 2003-09-09 | Sepracor Inc. | Carbonate and carbamate modified forms of glucocorticoids |
EP1713506A1 (en) * | 2004-01-30 | 2006-10-25 | Pfizer Products Incorporated | Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration |
FR2873373B1 (fr) * | 2004-07-23 | 2006-09-08 | Sanofi Synthelabo | Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique |
GB2452696B (en) * | 2007-08-02 | 2009-09-23 | Cambridge Entpr Ltd | 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions |
DE102008015428A1 (de) * | 2008-03-20 | 2009-09-24 | Beiersdorf Ag | Kühlende Zubereitungen für den humanen Haut- und/oder Schleimhautkontakt mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid |
DE102008015426A1 (de) * | 2008-03-20 | 2009-09-24 | Beiersdorf Ag | Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid zu Reduktion von Hautrötungen |
DE102008015425A1 (de) * | 2008-03-20 | 2010-01-21 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen zur Verringerung von Juckreiz und anderen dermatologischen Missempfindungen, die insbesondere bei Altershaut auftreten können, mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US512901A (en) * | 1894-01-16 | Folding bed | ||
GB821012A (en) * | 1957-01-15 | 1959-09-30 | Rhone Poulenc Sa | New phenthiazine derivatives and processes for their preparation |
FR2676055B1 (fr) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
CA2198084C (en) | 1994-08-25 | 2000-03-28 | Timothy P. Burkholder | Novel substituted piperidines useful for the treatment of allergic diseases |
CA2162786A1 (en) | 1994-11-22 | 1996-05-23 | Philip Arthur Hipskind | Heterocyclic tachykinin receptor antagonists |
-
1999
- 1999-04-07 FR FR9904429A patent/FR2789390B3/fr not_active Expired - Lifetime
-
2000
- 2000-02-08 ID IDW00200101651A patent/ID29219A/id unknown
- 2000-02-08 AT AT00903744T patent/ATE370942T1/de not_active IP Right Cessation
- 2000-02-08 NZ NZ513053A patent/NZ513053A/xx not_active IP Right Cessation
- 2000-02-08 WO PCT/FR2000/000284 patent/WO2000047572A1/fr active IP Right Grant
- 2000-02-08 CN CNB008058261A patent/CN1273463C/zh not_active Expired - Fee Related
- 2000-02-08 ES ES00903744T patent/ES2291187T3/es not_active Expired - Lifetime
- 2000-02-08 RU RU2001121989/04A patent/RU2220956C2/ru not_active IP Right Cessation
- 2000-02-08 EE EEP200100417A patent/EE04437B1/xx not_active IP Right Cessation
- 2000-02-08 BR BR0008067-5A patent/BR0008067A/pt not_active Application Discontinuation
- 2000-02-08 PL PL350243A patent/PL198561B1/pl not_active IP Right Cessation
- 2000-02-08 RS YUP-564/01A patent/RS50210B/sr unknown
- 2000-02-08 US US09/913,106 patent/US6642233B1/en not_active Expired - Fee Related
- 2000-02-08 CZ CZ20012888A patent/CZ300765B6/cs not_active IP Right Cessation
- 2000-02-08 ME MEP-119/08A patent/MEP11908A/xx unknown
- 2000-02-08 TR TR2001/02331T patent/TR200102331T2/xx unknown
- 2000-02-08 IL IL14436300A patent/IL144363A0/xx not_active IP Right Cessation
- 2000-02-08 DE DE60036081T patent/DE60036081T2/de not_active Expired - Lifetime
- 2000-02-08 DK DK00903744T patent/DK1150970T3/da active
- 2000-02-08 EP EP00903744A patent/EP1150970B1/fr not_active Expired - Lifetime
- 2000-02-08 SI SI200030968T patent/SI1150970T1/sl unknown
- 2000-02-08 JP JP2000598492A patent/JP4648544B2/ja not_active Expired - Fee Related
- 2000-02-08 UA UA2001075184A patent/UA70986C2/uk unknown
- 2000-02-08 CA CA002360894A patent/CA2360894C/en not_active Expired - Fee Related
- 2000-02-08 SK SK1139-2001A patent/SK286401B6/sk not_active IP Right Cessation
- 2000-02-08 AU AU25531/00A patent/AU763716B2/en not_active Ceased
- 2000-02-08 HU HU0201281A patent/HUP0201281A3/hu unknown
- 2000-02-08 KR KR1020017009983A patent/KR100611261B1/ko not_active IP Right Cessation
- 2000-02-08 PT PT00903744T patent/PT1150970E/pt unknown
- 2000-02-09 TW TW089102106A patent/TWI254712B/zh active
- 2000-02-09 AR ARP000100555A patent/AR028813A1/es active IP Right Grant
- 2000-02-10 PE PE2000000102A patent/PE20001463A1/es not_active Application Discontinuation
- 2000-02-10 CO CO00008757A patent/CO4980896A1/es unknown
-
2001
- 2001-07-26 HR HR20010566A patent/HRP20010566A2/hr not_active Application Discontinuation
- 2001-08-08 BG BG105794A patent/BG65031B1/bg unknown
- 2001-08-08 NO NO20013878A patent/NO321149B1/no not_active IP Right Cessation
-
2002
- 2002-01-29 HK HK02100715A patent/HK1038927A1/xx not_active IP Right Cessation
-
2003
- 2003-09-16 US US10/663,124 patent/US6951940B2/en not_active Expired - Fee Related
-
2005
- 2005-04-21 NO NO20051958A patent/NO20051958L/no unknown
-
2007
- 2007-01-07 IL IL180579A patent/IL180579A0/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR014261A1 (es) | Compuestos hipolipidemicos de benzotiazepina, composiciones y proceso para su preparacion | |
MEP24508A (en) | Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | |
IS6451A (is) | Nýjar 1,3-díhýdró-2H-indól-2-ón afleiður, framleiðsluaðferð og lyfjasamsetningar sem innihalda þær | |
HRP20041137B1 (hr) | Indolni, azaindolni i srodni heterocikliäśni 4-alkenil piperidinski amidi | |
MEP45308A (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
HUP0101511A2 (hu) | 1-[(1-Szubsztituált-4-piperidinil)-metil]-4-piperidin-származékok, eljárás a vegyületek előállítására, a vegyületeket tartalmazó gyógyászati készítmények és intermedierjeik | |
EA200500342A1 (ru) | Гетероциклические замещённые пиперазины для лечения шизофрении | |
RU94038064A (ru) | Производные пиперазина и пиперидина, их применение в качестве противопсихотических средств, способ их получения фармацевтическая композиция | |
MEP51408A (en) | Selected cgrp antagonists, method for production and use thereof as medicament | |
FI98460B (fi) | Menetelmä terapeuttisesti käyttökelpoisen 4H-1-bentsopyran-4-onijohdoksen tai sen suolan valmistamiseksi ja menetelmässä käyttökelpoinen välituote | |
YU56995A (sh) | Soli derivata indola | |
MEP9309A (en) | Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same | |
BRPI0406717A (pt) | Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção | |
FR2804115B1 (fr) | Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant | |
DE60208178D1 (de) | Chinolin-4-carboxamidderivate als nk-3 und nk-2 rezeptor antagonisten | |
MEP11908A (en) | (1-phenacy-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same | |
IL61285A0 (en) | 2-hydroxyalkyl-3,4,k-trihydroxy-piperidine compounds, their production and pharmaceutical compositions containing them | |
YU68201A (sh) | Novi derivati morfolina, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže | |
ATE400563T1 (de) | Neue neurokinin-antagonisten zum gebrauch als arzneimittel | |
NO20055754L (no) | Kolkisosidanaloger | |
EA200301087A1 (ru) | Новые пиперидинкарбоксамидные производные, способ их получения и содержащие их фармацевтические композиции | |
EA200200610A1 (ru) | НОВЫЕ ЗАМЕЩЕННЫЕ ПИРАЗОЛО [4,3-е]ДИАЗЕПИНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ИХ, ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ ПРОДУКТОВ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ | |
EA200000530A1 (ru) | НОВЫЕ 19-НОРСТЕРОИДЫ, ЗАМЕЩЕННЫЕ В ПОЛОЖЕНИИ 11β, СПОСОБ И ПРОМЕЖУТОЧНЫЕ ПРОДУКТЫ ДЛЯ ИХ ПОЛУЧЕНИЯ, ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ | |
HUP0401895A2 (hu) | Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
PT75925A (fr) | Procede de preparation de derives de diaza-3,7a cyclohepta <j,k>fluorenes et de compositions pharmaceutiques les contenant |